Over 11 years of stable renal function after remission of nephrotic-range proteinuria in type I diabetics treated with an ACE inhibitor

Nephron

Volumn 76, Issue 3, 1997, Pages 270-275

  McGregor, David ^a   Bailey, Ross R ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Albuminuria; Angiotensin converting enzyme inhibitors; Diabetic nephropathy; Hypertension; Nephrotic range proteinuria; Type I diabetics

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; DRUG EFFICACY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY;

EID: 0030754537     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190191     Document Type: Article

References (13)

1. Breycr JA: Diabetic nephropathy in insulin-dependent patients, Am J Kidney Dis 1992:20: 533-547.
2. Austin SM, Lieberman JS, Newton LD, Mejia M, Peters WA, Myers BD: Slope of serial glomerular filtration rate and the progression of diabetic glomerular disease, J Am Soc Nephrol 1993;3:1358-1370.
3. Gault MH, Fernandez D: Stable renal function in insulin-dependent diabetes mellitus 10 years after nephrotic range proteinuria, Nephron 1996;72:86-92.
4. Herbert LA, Bain RP, Vcrme D, Cattran D, Whittier FC, Tolchin N, Rohde RD, Lewis EJ: Remission of nephrotic range proteinuria in type I diabetes, Kidney Int 1994;46:1688-1693.
5. Abouna GM, Krcmer GD, Daddah SK, et al: Reversal of diabetic nephropathy in human cadaveric kidneys into non-diabetic recipients, Lancet 1983:2:1274-1276.
6. The Diabetes Control and Complications Research Group: The effect of intensive treatment of diabetes on the development of long-term complications in insulin dependent diabetes mellitus, N Engl J Med 1993;329:1035-1036.
7. Manto A, Cotronco P, Marra G, Magnani P, Tilli P, Greco A, Ghirlanda G: Effect of intensive treatment on diabetic nephropathy in patients with type I diabetes, Kidney Int 1995:47: 231-235.
8. Krolewski AS, Warrant JH, Christlieb AR: Hypercholesterolemia: A determinant of renal function loss and deaths in IDDM patients with nephropathv, Kidney Int 1994;45(suppl): 125-131.
9. Parving H-H, Smidt UM, Hommel E, Mathie-sen ER, Rossing P, Nielsen F, Gall M-A: Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy, Am J Kidney Dis 1993:22:188-195.
10. Rossing P, Hommel E, Smidt UM, Parving H-H: Reduction in albuminuria predicts diminished progression in diabetic nephropathy, Kidney Int 1994;45(suppl 451)145-149.
11. Remizzi G, Bertani T: Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules? Kidney Int 1990:38: 384-394.
12. Kasiske BL, Kalil RSN, Ma JZ, Liao M, Keane WF: Effect of antihypertensive therapy in the kidney in patients with diabetes: A metaregrcs-sior, analvsis, Ann Intern Med 1993; 118:129-138.
13. Viberti G, Mogensen CE, Groop LC, Pauls JF, forthe European Microalbuminuria Captopril Study Group: Effect of captopril on progression to clinical proteinuria in patients with insulin dependent diabetes and microalbuminuria, JAMA 1994:271:275-279.